Medicine and Dentistry
Heart Failure
85%
Randomized Controlled Trial
57%
Telerehabilitation
46%
Heart Muscle Perfusion
25%
Heart Rehabilitation
22%
Coronary Artery Disease
21%
Rehabilitation Engineering
20%
Hyperaemia
18%
Drug Therapy
17%
Screening
15%
Shared Care
15%
Mass Screening
15%
Amlodipine
15%
Metoprolol
15%
Quality of Life
14%
Glyceryl Trinitrate
12%
Dipyridamole
12%
Placebo
12%
Prevalence
11%
Cardiovascular System
11%
Cardiovascular Disease
10%
Chronic Obstructive Pulmonary Disease
10%
Percutaneous Coronary Intervention
10%
Outpatient
10%
General Practitioner
10%
Acetylsalicylic Acid
9%
Health Care Cost
9%
Exercise
9%
Heart Failure with Reduced Ejection Fraction
8%
Cost-Effectiveness Analysis
8%
Vericiguat
8%
Cohort Analysis
8%
Heart Muscle Ischemia
8%
Arteriosclerosis Obliterans
8%
Abdominal Aortic Aneurysm
8%
General Medicine
8%
Arm
8%
Muscle Strength
8%
Conditioning
7%
Guanylate Cyclase Activator
7%
Thrombocyte Function
7%
Carvedilol
7%
Patient with Congestive Heart Failure
7%
Ticagrelor
7%
LDL Receptor
7%
Patient with Diabetes
7%
Glycemic Control
7%
Ischemic Cardiomyopathy
7%
Metabolic Regulation
7%
Receptor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Placebo
41%
Acetylsalicylic Acid
39%
Coronary Artery Disease
33%
Heart Failure with Reduced Ejection Fraction
25%
Vericiguat
24%
Rivaroxaban
23%
Sacubitril Plus Valsartan
22%
Bleeding
21%
Enalapril
20%
Membrane Metalloendopeptidase
16%
Ticagrelor
15%
Heart Infarction
13%
Hemoglobin A1c
11%
Angiotensin Receptor
9%
Heart Muscle Ischemia
9%
Non Insulin Dependent Diabetes Mellitus
9%
Cardiovascular Disease
9%
Diabetes Mellitus
9%
Angiotensin
9%
Chronic Obstructive Lung Disease
8%
Beta Adrenergic Receptor Blocking Agent
8%
Guanylate Cyclase
8%
Guanylate Cyclase Activator
8%
Peripheral Occlusive Artery Disease
8%
Antithrombotic Therapy
7%
Randomized Controlled Trial
7%
Carotid Artery Disease
7%
Impaired Glucose Tolerance
7%
Congestive Heart Failure
7%
Isosorbide Dinitrate
7%
Carvedilol
7%
Heart Ventricle Remodeling
7%
Acute Coronary Syndrome
7%
Glyceryl Trinitrate
7%
Ischemic Cardiomyopathy
7%
Inflammation
7%
All Cause Mortality
7%
Prevalence
5%
Nursing and Health Professions
Heart Failure
61%
Telerehabilitation
38%
Heart Rehabilitation
22%
Coronary Artery Disease
17%
Rehabilitation Engineering
15%
Shared Care
15%
Quality of Life
14%
Outpatient
9%
Heart Muscle Ischemia
8%
General Practice
8%
Compliance
8%
Obstructive Lung Disease
7%
Acute Coronary Syndrome
7%
Rivaroxaban
7%
Placebo
7%
Thrombocyte Function Analyzer
7%
Heart Ventricle Remodeling
7%
Tidal Volume
7%
Telehealth
7%
Inflammation
7%
Beta Adrenergic Receptor Blocking Agent
7%
Cholesterol Blood Level
7%
Mass Screening
7%
Patient-Reported Outcome
7%
Cost Utility Analysis
7%
Carvedilol
7%
Patient with Congestive Heart Failure
7%
Health Care Personnel
5%
General Practitioner
5%
Volunteer
5%
